|
Mechanismβ-adrenoceptors antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date18 Aug 1966 |
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for the treatment of dermatophytic onychomycosis (toenail) without matrix involvement - ONICO
Efficacy and tolerance of V0071 GM 01A in inflammatory seborrhoeic dermatitis of the scalp.
A multicentre, open-label, repeated-dose, pharmacokinetic study of Propranolol in infants treated for proliferating infantile hemangiomas (IHs) requiring systemic therapy.
100 Clinical Results associated with Pierre Fabre Dermatologie SAS
0 Patents (Medical) associated with Pierre Fabre Dermatologie SAS
100 Deals associated with Pierre Fabre Dermatologie SAS
100 Translational Medicine associated with Pierre Fabre Dermatologie SAS